ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05321	Inflammatory bowel disease (IBD)	7/130	56/7206	5.88100911494e-05
ko04612	Antigen processing and presentation	8/130	77/7206	6.69443319088e-05
ko04630	Jak-STAT signaling pathway	10/130	132/7206	0.000124939667358
ko05164	Influenza A	11/130	167/7206	0.000199668234143
ko04658	Th1 and Th2 cell differentiation	8/130	96/7206	0.000316808398338
ko05168	Herpes simplex infection	11/130	182/7206	0.000420779911309
ko05145	Toxoplasmosis	9/130	126/7206	0.000426029086775
ko05162	Measles	8/130	120/7206	0.00139954157688
ko00590	Arachidonic acid metabolism	5/130	52/7206	0.0023315819943
ko04659	Th17 cell differentiation	7/130	106/7206	0.00293421957351
ko00061	Fatty acid biosynthesis	3/130	17/7206	0.00324215209286
ko04672	Intestinal immune network for IgA production	4/130	37/7206	0.00421296846169
ko00140	Steroid hormone biosynthesis	4/130	41/7206	0.00611194691652
ko04060	Cytokine-cytokine receptor interaction	9/130	191/7206	0.00746851032884
ko00564	Glycerophospholipid metabolism	6/130	99/7206	0.00876147693485
ko04140	Autophagy - animal	8/130	164/7206	0.00941282826043
ko05161	Hepatitis B	8/130	173/7206	0.0127388005841
ko04137	Mitophagy - animal	5/130	82/7206	0.015960033767
ko04142	Lysosome	7/130	151/7206	0.0191203516989
ko05152	Tuberculosis	8/130	187/7206	0.0195253368719
ko00052	Galactose metabolism	3/130	33/7206	0.021102451048
ko04622	RIG-I-like receptor signaling pathway	4/130	62/7206	0.0252273851541
ko04145	Phagosome	7/130	162/7206	0.0268848047596
ko00982	Drug metabolism - cytochrome P450	3/130	37/7206	0.0285340584443
ko02010	ABC transporters	3/130	39/7206	0.0327049942146
ko04380	Osteoclast differentiation	6/130	134/7206	0.0338444857739
ko05200	Pathways in cancer	3/130	492/7206	0.0343805317448
ko00980	Metabolism of xenobiotics by cytochrome P450	3/130	40/7206	0.0349033058893
ko00254	Aflatoxin biosynthesis	1/130	2/7206	0.0357580418665
ko00051	Fructose and mannose metabolism	3/130	42/7206	0.0395235189576
ko00565	Ether lipid metabolism	3/130	42/7206	0.0395235189576
ko05332	Graft-versus-host disease	2/130	18/7206	0.0409241015693
ko04217	Necroptosis	7/130	178/7206	0.041652293968
ko00592	alpha-Linolenic acid metabolism	2/130	19/7206	0.0452092791784
ko05140	Leishmaniasis	4/130	75/7206	0.046059471161
ko01524	Platinum drug resistance	4/130	76/7206	0.0479646329581
ko00120	Primary bile acid biosynthesis	2/130	20/7206	0.049651963547